Incidence of Hyperuricemia Related Backache in Patients among General Population
Objective: The main aim of this study was to find the Hyperuricemia related backache in patients among general population.
Place and duration of study: This study was carried out in a duration of 10 months from June 2018 to March 2019 in Medical departments of Jinnah Hospital Lahore.
Materials and Methods: A total of 100 patients were included in this study. Our study included both male and female patients with ages between 12-80 years. Patients which presented in outdoor with lower back pain were included and those with osteomalacia and chronic renal failure were excluded from this study. Informed consent was taken from all the patients and ethical committee approval was taken. A predesigned proforma was used to collect the data. Normal values of uric acid were taken in males as 4-7.0mg/dl and in females as 4-5.7mg/dl. Uric acid levels were checked by blood test which were sent to a reliable laboratory.
Results: A total of 100 patients including both males and females were included in this study with the ages between 12-80 years. Female patients were 54 while male patients were 46. Hyperuricemia was seen in 17 patients. According to age distribution, patients with age less than 40 years were 57 while those with age above 40 years were 43. Hyperuricemia in age group above 40 years was noted in 13 (76.47%) patients and (23.53%) 4 patients in other age group.
Conclusion: Among general population in Pakistan, frequency of Hyperuricemia is much higher and it must be considered seriously in patients with back pain particularly in female patients with higher age who are prone to develop this condition later in life.
Afzal N, Mahmud TE, Jahan SS, Kundi S. Uric acid profile in patients with chronic nonspecific musculoskeletal pain. J Ayub Med Coll Abbottabad. 2003;15(4):5-9.
Lindsey A. MacFarlane, Seoyoung C. Kim Gout: a review of non-modifiable and modifiable risk factors. Rheum Dis Clin North Am. 2014; 40(4): 581–4.
Ouédraogo DD, Ntsiba H, TiendrébéogoZabsonré J, Tiéno H, Bokossa LI, Kaboré F, Drabo J. Clinical spectrum of rheumatologic diseases in a department of rheumatology in Ouagadougou (Burkina Faso). Clin Rheumatol. 2014; 33(3):385-9.
Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, Arroll B, Thornley S, Gribben B, Dalbeth N. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford). 2012;51(5):901-9.
Qiliang Liu, Gamble G, Pickering K, Morton S, Dalbeth N. Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes. Rheumatology (Oxford). 2012;51(4):757-59.
Grady EP, Carpenter MT, Koenig CD, Older SA, Battafarano DF. Rheumatic findings in Gulf War veterans. Arch Intern Med. 1998;158(4):367-71.
Hsu HJ, Yen CH, Hsu KH, Wu IW, Lee CC, Hung MJ, Sun CY, Chou CC, Chen YC, Hsieh MF, Chen CY, Hsu CY, Tsai CJ, Wu MS. Factors associated with
chronic musculoskeletal pain in patients with chronic kidney disease. BMC Nephrol. 2014;15:6.
Roddy E, Choi HK. Epidemiology of Gout. Rheum Dis Clin North Am. Rheum Dis Clin North Am. 2014; 40(2):155–75.
Wertheimer A, Morlock R, Becker MA. A Revised Estimate of the Burden of Illness of Gout. Curr Ther Res Clin Exp. 2013; 75: 1–4.
Maynard JW, McAdams-DeMarco MA, Law A, Kao L, Gelber AC, Coresh J, Baer AN. Racial Differences in Gout Incidence in a Population-Based Cohort: Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2014;179(5):576-83.
Öztürk MA1, Kaya A, Şenel S, Dönmez S, Balkarlı A, Çobankara V, Erhan Ç, Sayarlıoğlu M, Ugan Y, Tunç ŞE, Pehlivan Y, Kısacık B, Tufan A, Onat AM, Tezcan E, Yıldırım Çetin G, Pamuk ON. Demographic and clinical features of gout patients in Turkey: a multicenter study. Rheumatol Int. 2013;33(4):847-52.
Chen JH, Yeh WT, Chuang SY, Wu YY, Pan WH. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol. 2012;31(2):239-45.
Gaffo AL, Jacobs DR, Lewis CE, Mikuls TR, Saag KG. Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthritis Res Ther. 2012;14(1): R4
Stamp LK, Wells JE, Pitama S, Faatoese A, Doughty RN, Whalley G, Richards AM, Cameron VA. Hyperuricaemia and gout in New Zealand rural and urban Maori and non-Maori communities. Intern Med J. 2013;43(6):678-84.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.